Cellular Starting Materials Market Size, Share, By Type (Leukopaks, and Cells & Tissues), By Grade (Good Manufacturing Practice, and Research), By End-Use (Cell Therapy, Research & Development, and Others), and By Region - Trends, Analysis, and Forecast till 2034

Report Code: PMI555424 | Publish Date: August 2024 | No. of Pages: 185

Cellular Starting Materials Market Companies

  • AcceGen
  • AllCells
  • Anthony Nolan
  • BioIVT
  • CGT GLOBAL
  • Charles River Laboratories
  • Excellos
  • HumanCells Bio
  • NMDP BioTherapies.
  • STEMCELL Technologies

Recent News:

  • Charles River Laboratories International Inc. will introduce its new CliniPrime line of GMP-compliant cellular starting materials in January 2023. CliniPrime products provide immediate access to starting materials for cell and gene-modified cell therapies and a standardized manufacturing procedure that yields high-quality GMP-compliant products. All CliniPrime products meet the primary regulatory standards for clinical trial development and commercial manufacture of novel medicines. The CliniPrime Fresh Leukopak will help clients speed up the development of novel drugs for clinical trials that potentially offer life-saving therapeutic options.